We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04513925
Brief Title: A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) (SKYSCRAPER-03)

First Submitted : August 13, 2020
First Submitted that Met QC Criteria : August 13, 2020
First Posted : August 14, 2020

Last Update Submitted that Met QC Criteria : January 26, 2023
Last Update Posted : January 30, 2023